Anumana’s ECG Pulmonary Hypertension AI Algorithm Gains Breakthrough Status
Related Articles
Midwest providers eye new financial opportunities
Modern Healthcare: Mayo Clinic announced a new technology platform initiative to deliver the next generation of clinical decision support tools, diagnostic insights and care recommendations to help clinicians make faster…{post_date: F d, Y}
AI researchers at Mayo Clinic use the Apple Watch to detect silent, weakening heart disease
FIERCE Biotech: Using simplified ECG data taken from an Apple Watch, researchers at the Mayo Clinic were able to use an artificial intelligence algorithm to spot people whose hearts may…{post_date: F d, Y}
FDA grants Breakthrough Device Designation to pulmonary hypertension early detection AI
Pharma File: Anumana has announced the FDA had granted breakthrough Device Designation to its AI-enhanced ECG-based Pulmonary Hypertension (PH) Early Detection Algorithm. Breakthrough Device Designations recognise novel innovations demonstrating potential…{post_date: F d, Y}
Novartis turns to algorithms developer Anumana to apply AI to cardio conditions
Med City News: Novartis is partnering with algorithms startup Anumana to develop a new artificial intelligence-based solution for cardiovascular diseases. The goal is to find ways to detect heart conditions…{post_date: F d, Y}